Hakan Çetin

1.1k total citations
49 papers, 590 citations indexed

About

Hakan Çetin is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hakan Çetin has authored 49 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 14 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hakan Çetin's work include Myasthenia Gravis and Thymoma (16 papers), Peripheral Neuropathies and Disorders (11 papers) and Amyotrophic Lateral Sclerosis Research (6 papers). Hakan Çetin is often cited by papers focused on Myasthenia Gravis and Thymoma (16 papers), Peripheral Neuropathies and Disorders (11 papers) and Amyotrophic Lateral Sclerosis Research (6 papers). Hakan Çetin collaborates with scholars based in Austria, United Kingdom and Germany. Hakan Çetin's co-authors include Fritz Zimprich, Angela Vincent, Richard Webster, Jakob Rath, David Beeson, Gudrun Zulehner, Eduard Auff, Martin Krenn, Heidemarie Zach and Inga Koneczny and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Brain.

In The Last Decade

Hakan Çetin

47 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hakan Çetin Austria 16 390 147 91 66 56 49 590
Shuuichi Mori Japan 11 211 0.5× 224 1.5× 141 1.5× 44 0.7× 42 0.8× 21 569
André Macedo Serafim da Silva Brazil 10 153 0.4× 121 0.8× 29 0.3× 28 0.4× 88 1.6× 33 323
Mariano Marrodán Argentina 14 171 0.4× 91 0.6× 46 0.5× 39 0.6× 23 0.4× 39 570
Marios Kaliakatsos United Kingdom 12 75 0.2× 83 0.6× 48 0.5× 64 1.0× 14 0.3× 31 411
Jürgen Prestel Germany 9 135 0.3× 126 0.9× 18 0.2× 79 1.2× 17 0.3× 10 365
Jeremy D. Rubinstein United States 13 91 0.2× 119 0.8× 37 0.4× 65 1.0× 19 0.3× 39 455
Reid Longmuir United States 12 173 0.4× 63 0.4× 38 0.4× 38 0.6× 8 0.1× 26 398
Muhammad Talal Alrifai Saudi Arabia 12 136 0.3× 157 1.1× 31 0.3× 47 0.7× 11 0.2× 28 444
J L Capablo Spain 11 166 0.4× 70 0.5× 34 0.4× 37 0.6× 14 0.3× 24 367

Countries citing papers authored by Hakan Çetin

Since Specialization
Citations

This map shows the geographic impact of Hakan Çetin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakan Çetin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakan Çetin more than expected).

Fields of papers citing papers by Hakan Çetin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakan Çetin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakan Çetin. The network helps show where Hakan Çetin may publish in the future.

Co-authorship network of co-authors of Hakan Çetin

This figure shows the co-authorship network connecting the top 25 collaborators of Hakan Çetin. A scholar is included among the top collaborators of Hakan Çetin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakan Çetin. Hakan Çetin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krenn, Martin, Axel Schmidt, Matias Wagner, et al.. (2025). AlphaMissense prediction for the evaluation of missense variants in the diagnostic setting of neuromuscular disorders. Journal of Neuromuscular Diseases. 708678093–708678093.
2.
Klotz, Sigrid, Theresa König, Lukas Haider, et al.. (2024). Clinical heterogeneity within the ALS‐FTD spectrum in a family with a homozygous optineurin mutation. Annals of Clinical and Translational Neurology. 11(6). 1579–1589. 1 indexed citations
3.
Vincent, Angela, et al.. (2024). A clinical perspective on muscle specific kinase antibody positive myasthenia gravis. Frontiers in Immunology. 15. 1502480–1502480. 1 indexed citations
4.
Wurm, Raphael, Astrid C. Erber, Stefan Leitner, et al.. (2024). Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease. JAMA Neurology. 82(2). 185–185. 2 indexed citations
5.
Rath, Jakob, et al.. (2023). The diagnostic and prognostic utility of repetitive nerve stimulation in patients with myasthenia gravis. Scientific Reports. 13(1). 2985–2985. 11 indexed citations
6.
Bruno, Verónica, Hakan Çetin, Wolfgang Bauer, et al.. (2022). A systematic review and meta-analysis of HLA class II associations in patients with IgG4 autoimmunity. Scientific Reports. 12(1). 9229–9229. 14 indexed citations
7.
Çetin, Hakan, David T. Liu, Franco Laccone, et al.. (2022). A homozygous AP3D1 missense variant in patients with sensorineural hearing loss as the leading manifestation. Human Genetics. 142(8). 1077–1089. 3 indexed citations
8.
König, Theresa, Raphael Wurm, Christoph Hotzy, et al.. (2022). C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients. Neurobiology of Disease. 175. 105927–105927. 6 indexed citations
9.
10.
Çetin, Hakan, Jiangwei Sun, Catarina Almqvist, et al.. (2020). No association between proton pump inhibitor use and ALS risk: a nationwide nested case–control study. Scientific Reports. 10(1). 13371–13371. 5 indexed citations
11.
Erber, Astrid C., Hakan Çetin, David Berry, & Eva Schernhammer. (2019). The role of gut microbiota, butyrate and proton pump inhibitors in amyotrophic lateral sclerosis: a systematic review. International Journal of Neuroscience. 130(7). 727–735. 19 indexed citations
12.
Rath, Jakob, Gudrun Zulehner, Eva Hilger, et al.. (2019). Frequency and clinical features of treatment-refractory myasthenia gravis. Journal of Neurology. 267(4). 1004–1011. 23 indexed citations
13.
Saxena, Abhishek, Jo Stevens, Hakan Çetin, et al.. (2017). Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient. Scientific Reports. 7(1). 14426–14426. 15 indexed citations
14.
Rath, Jakob, Matthias Mauritz, Gudrun Zulehner, et al.. (2017). Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study. Journal of Neurology. 264(6). 1209–1217. 4 indexed citations
15.
Çetin, Hakan, Fritz Leutmezer, Assunta Dal‐Bianco, et al.. (2017). Epidemiology of Multiple Sclerosis in Austria. Neuroepidemiology. 49(1-2). 40–44. 19 indexed citations
16.
Çetin, Hakan, et al.. (2015). OKUL YÖNETİCİLERİNİN EĞİTİM YÖNETİMİ BİLGİ SİSTEMLERİNE İLİŞKİN GÖRÜŞLERİ: MEMNUNİYET, ALGILANAN FAYDA VE GÖREVE UYGUNLUK ARASINDAKİ İLİŞKİ. Balıkesir Üniversitesi Sosyal Bilimler Enstitüsü Dergisi. 18(34). 193–212. 1 indexed citations
17.
Çetin, Hakan, Jakob Rath, Berthold Reichardt, et al.. (2015). Epidemiology of Amyotrophic Lateral Sclerosis and Effect of Riluzole on Disease Course. Neuroepidemiology. 44(1). 6–15. 38 indexed citations
18.
Çetin, Hakan, Jakob Rath, Gudrun Zulehner, et al.. (2015). Associations between co-medications and survival in ALS—a cohort study from Austria. Journal of Neurology. 262(7). 1698–1705. 8 indexed citations
19.
Çetin, Hakan. (2014). KİŞİSEL VERİ GÜVENLİĞİ VE KULLANICILARIN FARKINDALIK DÜZEYLERİNİN İNCELENMESİ. DergiPark (Istanbul University). 14(29). 86–105. 4 indexed citations
20.
Çetin, Hakan, et al.. (2012). Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society. Wiener klinische Wochenschrift. 124(21-22). 763–768. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuuichi Mori Breakdown of academic impact, for papers by André Macedo Serafim da Silva Breakdown of academic impact, for papers by Mariano Marrodán Breakdown of academic impact, for papers by Marios Kaliakatsos Breakdown of academic impact, for papers by Jürgen Prestel Breakdown of academic impact, for papers by Jeremy D. Rubinstein Breakdown of academic impact, for papers by Reid Longmuir Breakdown of academic impact, for papers by Muhammad Talal Alrifai Breakdown of academic impact, for papers by J L Capablo
Rankless by CCL
2026